GIANNELLI, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 9.842
EU - Europa 1.825
AS - Asia 819
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 12.498
Nazione #
US - Stati Uniti d'America 9.831
CN - Cina 666
SE - Svezia 618
UA - Ucraina 249
IT - Italia 231
DE - Germania 221
FI - Finlandia 163
GB - Regno Unito 150
SG - Singapore 70
FR - Francia 60
BE - Belgio 48
IE - Irlanda 32
IN - India 27
VN - Vietnam 20
CZ - Repubblica Ceca 18
IR - Iran 14
JP - Giappone 10
CA - Canada 8
NL - Olanda 8
RU - Federazione Russa 6
AU - Australia 4
RO - Romania 4
HK - Hong Kong 3
HU - Ungheria 3
MX - Messico 3
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
ES - Italia 2
EU - Europa 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
LU - Lussemburgo 1
ME - Montenegro 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 12.498
Città #
Fairfield 1.404
Chandler 1.135
Woodbridge 1.075
Ashburn 739
Houston 653
Jacksonville 565
Seattle 554
Wilmington 517
Nyköping 511
Cambridge 480
Ann Arbor 402
Lawrence 208
Roxbury 202
Nanjing 167
Beijing 164
New York 124
Des Moines 110
Boardman 79
Inglewood 79
Princeton 77
San Diego 67
Brooklyn 54
Los Angeles 49
Bari 48
Brussels 46
Jiaxing 44
Singapore 44
Hebei 38
Shenyang 35
London 34
Tianjin 33
Dublin 32
Nanchang 32
Changsha 22
Helsinki 22
Washington 22
Paris 21
Redwood City 20
Dong Ket 19
Falls Church 17
San Mateo 17
Olomouc 15
Pune 15
Dearborn 14
Norwalk 13
Shanghai 13
Ardabil 12
Augusta 11
Guangzhou 11
Munich 11
Grumo Appula 10
Edinburgh 9
Jinan 9
Kilburn 9
Leawood 9
Milan 9
Strasbourg 9
Hangzhou 8
Ostuni 8
San Francisco 8
Zhengzhou 8
Taranto 7
Tokyo 7
Auburn Hills 5
Marseille 5
New Bedfont 5
Prescot 5
Taizhou 5
Wuhan 5
Amsterdam 4
Chiswick 4
Grafing 4
Hanover 4
Islington 4
Monmouth Junction 4
Naples 4
Ningbo 4
Redmond 4
Romainville 4
Rome 4
Stockholm 4
Toronto 4
Torrile 4
Triggiano 4
Yiwu 4
Brescia 3
Brno 3
Budapest 3
Genoa 3
Hounslow 3
Kunming 3
Mascalucia 3
Modena 3
Nakano 3
Phoenix 3
Sannicandro di Bari 3
Santa Marinella 3
Shenzhen 3
Sydney 3
Aci Castello 2
Totale 10.324
Nome #
Social dysfunction in older age and relationships with cognition, depression, and apathy: The GreatAGE Study 128
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 125
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 124
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 124
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 115
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 110
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 108
A pegylated interferon alpha-2b dose-reduction in HCV 1b patients with rapid virological response does not affect sustained virological response 102
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 99
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma 98
Imaging modification of colon carcinoma cells exposed to lipid based nanovectors for drug delivery: a scanning electron microscopy investigation 98
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer 98
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma 95
.: Cancer invasion: watch your neighbourhood! 93
Hepatocytes activate HSC via MMP-9. Role of IFN-a2b in modulating liver fibrosis in HCV patients 92
The TGF-β pathway: a pharmacological target in hepatocellular carcinoma? 92
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives 91
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 91
Dietary ω-3 polyunsaturated fatty acids inhibit tumor growth in transgenic Apcmin/+ mice, correlating with CB1 receptor up-regulation 89
TGF-β and the tissue microenvironment: Relevance in fibrosis and cancer 88
Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids 87
Novel Transforming Growth Factor Beta Receptor I Kinase Inhibitor Galunisertib (LY2157299) in Advanced Hepatocellular Carcinoma 87
Rationale for new drugs targeting the tissue microenvironment in patients with HCC 86
Malignant fibrous histiocytoma arising on chronic osteomyelitis 86
Automatic transwell assay by an EIS cell chip to monitor cell migration 86
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells. 86
null 86
Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex-vivo cultures 85
Signaling networks in cholangiocarcinoma: molecular pathogenesis, targeted therapies and drug resistance 85
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 84
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline 84
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: A prospective clinical study 84
FZD10 Carried by Exosomes Sustains Cancer Cell Proliferation 84
Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: Results from a preclinical pilot study 83
Hepatic stellate cells stimulate HCC cell migration via laminin-5 production 82
Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model 82
Polymeric nano-micelles as novel cargo-carriers for LY2157299 liver cancer cells delivery 82
Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib 81
Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment 81
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease 80
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapy 80
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors 80
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease 80
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial 80
Aquaporin 9 contributes to the maturation process and inflammatory cytokine secretion of murine dendritic cells 80
Case of multiple myeloma mimicking an infectious disease with fever, intrahepatic cholestasis, renal failure, and pulmonary insufficiency 79
Gelatinase levels in male and female breast cancer 78
Transforming growth factor-β promotes morphomechanical effects involved in epithelial to mesenchymal transition in living hepatocellular carcinoma 78
Valore prognostico della neopterina nel siero di soggetti con infezione da HIV 77
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-a 77
TGF-Beta Inihibitor-loaded Polyelectrolyte Multilayers Capsules for Sustained Targeting of Hepatocarcinoma Cells 77
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? 76
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma 76
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 76
PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments 76
The epithelial-mesenchymal transition: fact or fiction in cancer? 75
MxA and PKR expression in chronic hepatitis C 75
null 75
Aerobic physical activity and a low glycemic diet reduce the AA/EPA ratio in red blood cell membranes of patients with NAFLD 75
Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5 74
2',5’-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C 74
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. 74
The rationale for targeting TGF-β in chronic liver diseases 74
Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial 73
Glaucoma in primary amyloidosis:a fortuitous or a causative association? 73
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients 73
Key enabling technologies for point-of-care diagnostics 72
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 72
null 72
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 70
SCCA Antigen combined with alpha-fetoprotein as serologic markers of HCC 70
null 70
null 70
Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link? 69
ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cells 69
A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection 69
Coffee intake and liver steatosis: A population study in a mediterranean area 69
Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5 68
null 68
Immune cells and microbiota response to iron starvation 68
Clinical outcomes of bosentan in pulmonary arterial hypertension do not correlate with levels of TIMPs 67
Proteolytic balance in patients with multiple sclerosis during interferon treatment 66
MxA and PKR expression in chronic hepatitis C 66
The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension 66
Dietary fiber and health outcomes: An umbrella review of systematic reviews and meta-analyses 66
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs 66
Association between adherence to the Mediterranean Diet and circulating Vitamin D levels 66
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. 65
Effects of interferon-alfa treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C 65
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study 64
Characterization of morphological and cytoskeletal changes in MCF10A breast epithelial cells plated on laminin-5: comparison with breast cancer cell line MCF7 64
Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism 64
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 63
Nutritional domains in frailty tools: Working towards an operational definition of nutritional frailty 63
null 63
Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients 62
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS geneencoded proteins 61
New frontiers in biomarkers for hepatocellular carcinoma 61
Differential tissue fatty acids profiling between colorectal cancer patients with and without synchronous metastasis 61
Relationship between inflammatory food consumption and age-related hearing loss in a prospective observational cohort: Results from the salus in Apulia study 61
Totale 7.982
Categoria #
all - tutte 57.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.982


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.957 0 257 115 361 369 199 334 325 414 225 247 111
2020/20212.175 156 150 135 215 270 114 183 179 156 290 168 159
2021/20221.474 78 163 31 81 70 113 66 102 107 85 241 337
2022/20232.793 365 303 192 280 353 345 26 318 451 26 89 45
2023/2024982 66 178 61 78 84 233 47 34 15 44 18 124
2024/2025138 91 47 0 0 0 0 0 0 0 0 0 0
Totale 12.911